Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.48 |
| ▸ | BRD4 | O60885 | 7/20 | 0.47 |
| ▸ | EGFR | P00533 | 5/20 | 0.47 |
| ▸ | JAK2 | O60674 | 3/20 | 0.47 |
| ▸ | JAK3 | P52333 | 2/20 | 0.47 |
| ▸ | JAK1 | P23458 | 1/20 | 0.47 |
| ▸ | WEE1 | P30291 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 3/20 | 0.44 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.44 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.43 |
| ▸ | CDK2 | P24941 | 2/20 | 0.43 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.43 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.43 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.43 |
| ▸ | CDK9 | P50750 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1633769 | 0.93 | HRH3 (0.43) | MAP4K1BRD4EGFRJAK3CCNA2 | |
| SCHEMBL12724944 | 0.91 | MARK3 (0.46) | BRD4JAK2JAK3JAK1CCNA2 | |
| SCHEMBL1633360 | 0.91 | RIPK2 (0.49) | JAK2JAK3JAK1TBK1CCNA2 | |
| SCHEMBL1633170 | 0.88 | MAP4K1 (0.49) | MAP4K1BRD4JAK2JAK3JAK1 | |
| SCHEMBL1632964 | 0.85 | USP2 (0.49) | BRD4EGFRCCNA2CDK2CDK5 | |
| SCHEMBL12724921 | 0.85 | SYK (0.44) | — | |
| SCHEMBL1634247 | 0.85 | SCN9A (0.46) | MAP4K1 | |
| SCHEMBL1633193 | 0.83 | EGFR (0.46) | MAP4K1EGFR | |
| SCHEMBL12724942 | 0.81 | MARK3 (0.49) | BRD4JAK2JAK3JAK1TBK1 | |
| SCHEMBL1633595 | 0.80 | HRH3 (0.43) | MAP4K1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7932262-B2 | Quinazolines for PDK1 inhibition | NOVARTIS AG (CH) | 2011-04-26 | — | — | US | disclosed |